Monitoring of vascular endothelial growth factor in POEMS syndrome

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F10%3A10215298" target="_blank" >RIV/61989592:15110/10:10215298 - isvavai.cz</a>
Alternative codes found
RIV/00098892:_____/10:#0000346 RIV/00098892:_____/10:#0000399
Result on the web
—
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Monitoring of vascular endothelial growth factor in POEMS syndrome
Original language description
POEMS syndrome is a clinical unit with a very heterogenous clinical behavior. Its diagnostics as well as monitoring are not easy and depend on clinician´s experience. We present three case reports of patients with POEMS syndrome with different clinical manifestation and course of the disease. Our presentation demonstrates the benefit of the use of biochemical parameter VEGF (vascular endothelial growth factor). Retrospective analysis revealed that VEGF behaved accordingly with the state of the disease,i.e. it increased in active phase and decreased with remission of the disease. We suggest the use of VEGF not only the diagnostics but also as a potential marker of therapeutic response and for monitoring of the course of POEMS syndrome.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FE - Other fields of internal medicine
OECD FORD branch
—

Project
<a href="/en/project/NR9489" target="_blank" >NR9489: Significance of 18F-FDG PET/CT, whole body MRI and 99mTc-MIBI scintigraphy in diagnosis, clinical staging and monitoring of course of multiple myeloma</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2010
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)